Skip to main content

Non-compartmental Analysis

  • Protocol
  • First Online:
Book cover Computational Toxicology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 929))

Abstract

When analyzing pharmacokinetic data, one generally employs either model fitting using nonlinear regression analysis or non-compartmental analysis techniques (NCA). The method one actually employs depends on what is required from the analysis. If the primary requirement is to determine the degree of exposure following administration of a drug (such as AUC), and perhaps the drug’s associated pharmacokinetic parameters, such as clearance, elimination half-life, T max, C max, etc., then NCA is generally the preferred methodology to use in that it requires fewer assumptions than model-based approaches. In this chapter we cover NCA methodologies, which utilize application of the trapezoidal rule for measurements of the area under the plasma concentration–time curve. This method, which generally applies to first-order (linear) models (although it is often used to assess if a drug’s pharmacokinetics are nonlinear when several dose levels are administered), has few underlying assumptions and can readily be automated.

In addition, because sparse data sampling methods are often utilized in toxicokinetic (TK) studies, NCA methodology appropriate for sparse data is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gabrielsson J, Weiner D (2006) Pharmacokinetic and pharmacodynamic data analysis: concepts and applications, 4th edn. Swedish Pharmaceutical Press, Stockholm

    Google Scholar 

  2. Nakashima E, Benet LZ (1988) General treatment of mean residence time, clearance and volume parameters in linear mamillary models with elimination from any compartment. J Pharmacokinet Biopharm 16:475

    PubMed  CAS  Google Scholar 

  3. Nakashima E, Benet LZ (1989) An integrated approach to pharmacokinetic analysis for linear mammillary systems in which input and exit may occur in/from any compartment. J Pharmacokinet Biopharm 17:673

    PubMed  CAS  Google Scholar 

  4. Bailer AJ (1988) Testing for the equality of area under the curve when using destructive measurement techniques. J Pharmacokinet Biopharm 16:303

    PubMed  CAS  Google Scholar 

  5. Yeh C (1990) Estimation and significance tests of area under the curve derived from incomplete blood sampling. In: ASA Proceedings of the Biopharmaceutical Section, p 4

    Google Scholar 

  6. Nedelman JR, Jia X (1998) An extension of Satterthwaite’s approximation applied to pharmacokinetics. J Biopharm Stat 8(2):317

    Article  PubMed  CAS  Google Scholar 

  7. Hing JP, Woolfrey SG, Wright PMC (2001) Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data. J Pharmacokinet Pharmacodyn 28(5):465

    Article  PubMed  CAS  Google Scholar 

  8. Benet LZ (1972) General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. J Pharm Sci 61:536

    Article  PubMed  CAS  Google Scholar 

  9. Benet LZ, Galeazzi RL (1979) Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 48:1071

    Article  Google Scholar 

  10. Gibaldi M, Perrier D (1982) Pharmacokinetics. Revised and expanded, 2nd edn. Marcel Dekker Inc., New York, NY

    Google Scholar 

  11. Jusko WJ (1992) Guidelines for collection and analysis of pharmacokinetic data. In: Evans WE, Schentag JJ, Jusko WJ (eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, 3rd edn. Applied Therapeutics, Spokane, WA

    Google Scholar 

  12. Rowland M, Tozer T (2010) Clinical pharmacokinetics and pharmacodynamics: concepts and applications, 4th edn. Lippincott Williams & Wilkins, Maryland

    Google Scholar 

  13. Houston JB (1994) Kinetics of disposition of xenobiotics and their metabolites. Drug Metab Drug Interact 6:47

    Google Scholar 

  14. Pang KS (1985) A review of metabolic kinetics. J Pharmacokinet Biopharm 13(6):633

    PubMed  CAS  Google Scholar 

  15. Watari N, Benet LZ (1989) Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs. J Pharmacokinet Biopharm 17(1):593

    PubMed  CAS  Google Scholar 

  16. Gillespie WR (1991) Noncompartmental versus compartmental modeling in clinical pharmacokinetics. Clin Pharmacokinet 20:253

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Weiner .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Gabrielsson, J., Weiner, D. (2012). Non-compartmental Analysis. In: Reisfeld, B., Mayeno, A. (eds) Computational Toxicology. Methods in Molecular Biology, vol 929. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-050-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-050-2_16

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-049-6

  • Online ISBN: 978-1-62703-050-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics